School of Medicine
Showing 1-93 of 93 Results
-
Michelle Thi Cao
Clinical Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
Current Research and Scholarly InterestsPositive Airway Pressure devices for central sleep apnea
-
Robert W. Carlson
Professor of Medicine (Oncology and General Internal Medicine/Medical Informatics) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsClinical investigations in breast cancer include institutional and NSABP studies of chemoprevention, adjuvant therapy, psychosocial interventions, treatment of metastatic disease, methods of decreasing anthracycline cardiotoxicity, and modulation of multidrug resistance. Research in meta-analysis includes the performance of meta-analysis in a wide variety of settings in cancer treatment by the international Meta-Analysis Group in Cancer.
-
Chris Cartwright, MD
Professor of Medicine (Gastroenterology and Hepatology), Emerita
Current Research and Scholarly InterestsMolecular mechanisms of intestinal cell growth control; function and regulation of the Src family of tyrosine kinases in normal cells, and their deregulation in cancer cells.
-
Jennifer Caswell-Jin
Assistant Professor of Medicine (Oncology)
Current Research and Scholarly InterestsMy research is on the translational application of next-generation sequencing technologies to breast cancer care: (1) the value of hereditary cancer genetic panel testing in clinical practice, (2) the mechanisms by which inherited genetic variants lead to breast cancer development, and (3) the analysis of somatic tumor sequencing data to inform understanding of breast tumorigenesis, metastasis, and development of resistance in response to therapeutics.
-
Yashaar Chaichian, MD
Clinical Associate Professor, Medicine - Immunology & Rheumatology
Current Research and Scholarly InterestsSystemic lupus erythematosus
CTD-associated interstitial lung disease -
Julia J. Chang, MD
Clinical Assistant Professor, Medicine - Endocrinology, Gerontology, & Metabolism
Clinical Assistant Professor (By courtesy), NeurosurgeryBioDr. Chang is a board-certified endocrinologist. She is a Clinical Assistant Professor in Stanford Medicine’s Division of Endocrinology and, by courtesy, the Department of Neurosurgery. She specializes in pituitary disorders, including prolactinomas, Cushing disease, acromegaly, non-functional pituitary masses and cysts, and hypopituitarism, as well as transgender health and gender-affirming hormone care.
For each patient, she develops a comprehensive, compassionate care plan personalized to individual needs. Her goal is always the best possible health and quality of life for every patient in her care.
Dr. Chang actively leads several pituitary and transgender care research, quality improvement, and education initiatives. She teaches Stanford trainees and serves as the associate program director for the Stanford Endocrinology Fellowship. She has published widely and presented her research at international conferences and is a member of the Endocrine Society, Pituitary Society, and the World Professional Association of Transgender Health. She is a native English speaker, and she also understands Korean.
In-person and telehealth appointments with Dr. Chang are available at Stanford Endocrinology Clinic at Hoover Pavilion, Pituitary Center at Stanford Neurosciences Health Center, and the Stanford Brain Tumor Center at Stanford Cancer Center. She is also a part of the LGBTQ+ Health Program. -
Spencer Chang
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Spencer Chang is a board-certified Internal Medicine physician who practices at the Stanford Internal Medicine Clinic in Palo Alto. Dr. Chang earned his MD at Duke University School of Medicine where he was part of the Primary Care Leadership Track. He completed his Internal Medicine Residency training at UCLA in the Primary Care Program. Dr. Chang has interests in medical education, improving access to primary care, community health, and Asian Pacific Islander health disparities. He believes in a holistic approach to patient care, addressing the physical, mental, and emotional well-being of his patients and partnering with them to achieve their health goals.
-
Stephen Chang, MD, PhD
Instructor, Biochemistry
Instructor, Biochemistry
Instructor, Medicine - Cardiovascular MedicineBioPrior to a career in medicine, Dr. Chang was an English major and subsequent novelist at night. During the days, he taught literature part-time at Rutgers University, and for extra money, worked in a laboratory in NYC washing test tubes. Inspired by his laboratory mentor, he began volunteering at the hospital next door, and developed a love for interacting with patients. Through this experience, he saw how caring for others could form deep bonds between people - even strangers - and connect us in a way that brings grandeur to ordinary life.
In addition to seeing patients, Dr. Chang is a physician-scientist devoted to advancing the field of cardiovascular medicine. His research has been focused on identifying a new genetic organism that better models human heart disease than the mouse. For this purpose, he has been studying the mouse lemur, the smallest non-human primate, performing cardiovascular phenotyping (vital signs, ECG, echocardiogram) on lemurs both in-bred (in France) and in the wild (in Madagascar) to try to identify mutant cardiac traits that may be heritable - and in the process, characterize the first high-throughput primate model of human cardiac disease. -
Tara I. Chang
Stanford University Professor of Nephrology
Current Research and Scholarly InterestsMy research focuses on issues such as blood pressure control, coronary revascularization, and the comparative effectiveness of cardioprotective medications in patients with chronic kidney disease, with the long-term goal of improving cardiovascular outcomes in these high-risk patients.
-
Vivek Charu
Assistant Professor of Pathology and of Medicine (Quantitative Sciences)
BioI am a physician and a biostatistician. My clinical expertise is in the diagnosis of non-neoplastic kidney and liver disease (including transplantation). My research interests center on the design of observational studies and clinical trials, the analysis of observational data, and causal inference.
-
Amina Chaudhry, MD
Clinical Assistant Professor, Medicine - Oncology
BioDr. Amina Chaudhry is a medical oncologist in the Division of Oncology at Stanford University School of Medicine. As part of Stanford University’s Breast Cancer Program, she specializes in treating patients diagnosed with breast cancer.
Dr. Chaudhry completed a residency in internal medicine at the University of Tennessee Health Science Center. She gained advanced training in hematology and oncology through a fellowship at University of Illinois Chicago. She is certified by the American Board of Internal Medicine.
Dr. Chaudhry’s research focuses on improving outcomes in disadvantaged populations with breast cancer. In 2022, she received the Repurposing Research to Address Diversity, Equity, and Inclusion grant to support underrepresented patients with early-stage breast cancer.
Dr. Chaudhry has published research in journals including Annals of Oncology, Journal of Clinical Oncology, and Blood Advances. She has presented her work at the annual meetings of the American Society of Clinical Oncology (ASCO), San Antonio Breast Cancer Symposium (SABCS), and American Society of Hematology (ASH).
Dr. Chaudhry has a strong interest in tackling healthcare inequities and improving access to clinical trials. -
Christopher T Chen, MD
Assistant Professor of Medicine (Oncology)
BioDr. Chen is a board-certified, fellowship-trained specialist in oncology and hematology. He is also an Assistant Professor in the Division of Oncology in the Department of Medicine at Stanford University School of Medicine.
Dr. Chen delivers comprehensive, compassionate care for patients in need of early drug development clinical trials and patients with gastrointestinal cancers. As a researcher, he leads the early drug development group and studies how tumor heterogeneity limits the clinical benefit of anticancer therapies in order to accelerate development of novel therapeutic strategies. Dr. Chen’s work has appeared in the New England Journal of Medicine, JAMA, Journal of Clinical Oncology, Science Advances, Journal of Oncology Practice, and Health Services Research.
Dr. Chen attended Harvard College, where he graduated summa cum laude and Phi Beta Kappa in molecular biology. He went to medical school at Washington University in St. Louis on a full-tuition merit scholarship, graduating with Alpha Omega Alpha honors, and did his residency training in internal medicine at Massachusetts General Hospital and hematology/oncology fellowship in the combined Harvard Dana-Farber Cancer Institute/Massachusetts General Hospital program. As a fellow, he received the NIH T-32 Ruth L. Kirchstein-National Service Research Award in Cancer Biology for his work exploring the molecular structure of metastatic solid tumors.
Dr. Chen is a member of the American Society of Clinical Oncology, European Society for Medical Oncology, and American Association for Cancer Research. -
Eunice S. Chen, MD
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Chen is a board-certified family medicine doctor practicing concierge medicine. She is a clinical assistant professor in the Stanford Department of Medicine, Division of Primary Care and Population Health.
Her interests include primary care, women’s and men’s health, geriatric medicine, mental health, travel medicine, and preventive care.
Dr. Chen values the importance of mutual trust in a patient-doctor healthcare partnership. With compassion, sincerity, humility, and respect, she works closely with her patients in a collaborative spirit. Her goal is to help them navigate the pathway towards the best possible health and quality of life through shared decision making.
Each patient in the Stanford concierge medicine program enjoys a close relationship with one dedicated doctor. The doctor personalizes a plan of care to fit individual health, work, and lifestyle needs.
Around-the-clock access to a doctor, no matter where the patient is located, is an important feature of the concierge medicine program. Dr. Chen is committed to making her services as accessible as possible. She can meet patients via a video visit whenever requested and appropriate.
Patient reviews give high marks to Dr. Chen’s professional and personable approach to care. Patients praise her for being very knowledgeable and approachable, a good listener, and a clear communicator.
When not providing patient care, Dr. Chen enjoys spending time with family and friends, learning about different cultures, traveling, and discovering new food venues. -
Jonathan H. Chen, MD, PhD
Assistant Professor of Medicine (Biomedical Informatics) and of Biomedical Data Science
Current Research and Scholarly InterestsInformatics solutions ares the only credible approach to systematically address challenges of escalating complexity in healthcare. Tapping into real-world clinical data streams like electronic medical records will reveal the community's latent knowledge in a reproducible form. Delivering this back as clinical decision support will uniquely close the loop on a continuously learning health system.
-
Julie Chen
Clinical Assistant Professor, Medicine - Endocrinology, Gerontology, & Metabolism
BioJulie Chen, MD, is a board-certified endocrinologist and clinical assistant professor in the division of endocrinology at Stanford University. Dr. Chen diagnoses and treats a wide range of conditions with a focus on endocrine tumors that affect the thyroid, parathyroid, adrenal, and pituitary glands. She also works closely with cancer specialists to treat the endocrine side effects associated with immunotherapy. Dr. Chen recognizes that patients are more than their disease. She views her relationship with each patient as a partnership and develops a personalized care plan for each one. Dr. Chen is committed to helping patients achieve the best possible outcomes through comprehensive treatment.
Dr. Chen is also passionate about medical education and mentoring. She currently serves as the Program Director for the Endocrinology Fellowship Program at Stanford University. She has given numerous lectures to medical students, residents, and fellows. -
Meng Chen, MD
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Chen is a double board-certified, fellowship-trained specialist in allergy and immunology and internal medicine. She is a clinical assistant professor in the Department of Internal Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine at Stanford University School of Medicine.
With training in pediatric and adult allergy/immunology, Dr. Chen provides expertise in chronic urticaria, angioedema, drug allergy, severe asthma, food allergy and allergic rhinitis. She excels at addressing the impact of allergies on quality of life and productivity. Driven by a desire to help people and deliver exceptional care, Dr. Chen takes great pride in the effectiveness and efficiency of her services, her attention to detail, and the excellent patient satisfaction scores she earns. She has trained and worked in a broad range of clinical care settings, including private practice, the Veterans Administration, major health systems, and academic medical centers, like Stanford Health Care.
Dr. Chen has extensive research experience, from study start-up to manuscript preparation. Dr. Chen has authored numerous scholarly publications on topics including urticaria, angioedema and food allergies. She has presented the findings of her research to the American Academy of Allergy, Asthma, and Immunology Annual Scientific Meeting and other conferences. Her work has appeared in the journals Pediatric Allergy; the Annals of Allergy, Asthma, and Immunology; JAMA; as well as book chapters on immunology. Dr. Chen has received honors and awards for her scholarship. She is a member of the American Academy of Allergy, Asthma, and Immunology; the American College of Allergy, Asthma, and Immunology; and, the Allergy, Asthma, and Immunology Foundation of Northern California.
Dr. Chen’s academic passion is medical education and fostering the growth of medical trainees. She is particularly interested in harnessing the power of coaching to promote self-efficacy and wellness in medicine. She serves as the Well-Being Director for the Division of Pulmonary, Allergy, and Critical Care Medicine and also as a Faculty Coach in the School of Medicine’s Student Guidance Program. -
Paul Cheng MD PhD
Assistant Professor of Medicine (Cardiovascular Medicine)
BioDr. Cheng is a Cardiologist at Stanford University School of Medicine in the Department of Medicine and a member of the Cardiovascular Research Institute. Dr. Cheng received his BEng in Chemical Engineering and BSc in biology at MIT. He subsequently completed his MD/PhD at UCSF working in the Srivastava lab studying how extracellular morphogenic signals affect cardiac development and fate determination of cardiac progenitors. Dr. Cheng completed internal medicine residency and cardiology fellowship at Stanford. His current clinical focus is in amyloidosis and cardio-oncology. During his post doctoral research in the Quertermous lab, he pioneered the application of single cell transcriptomic and epigenetic techniques to study human vascular diseases including atherosclerosis and aneurysm, and applied these techniques to investigate molecular mechanisms behind genetic risk factors for several human vascular diseases including atherosclerosis, and aortopathies such as Marfan's and Loey-Dietz syndrome.
The Cheng lab takes a patient-to-bench-to-bedside approach to science. The lab focuses on elucidating new pathogenic mechanisms of human vascular diseases through combing human genetics and primary vascular disease tissues, with high-resolution transcriptomic and epigenetic profiling to generate novel hypothesis that are then tested in a variety of in vitro and in vivo models. The lab is focused on two broad questions: (1) understanding the biological underpinning of the differences in diseases propensities of different arterial segments in an individual (i.e. why do you have atherosclerosis and aneurysms in certain segments but not others), and (2) understanding the role of perivascular fibroblast in human vascular diseases.
Find out more about what the Cheng lab is up to, check out https://chenglab.sites.stanford.edu -
Xingxing Shelley Cheng
Assistant Professor of Medicine (Nephrology) and, by courtesy, of Surgery (Abdominal Transplantation) and of Health Policy
Current Research and Scholarly InterestsDr. Xingxing Cheng's expertise is in applying the tools of decision science to clinical practice and policy analysis. Her current research is in the following areas:
1) the costs, effectiveness, and implementation of work-up before kidney transplantation, including pretransplant cardiovascular screening;
2) ethics of and decision-making in in multi-organ transplantation. -
Glenn M. Chertow
Norman S. Coplon/Satellite Healthcare Professor of Medicine and Professor, by courtesy, of Epidemiology and Population Health and of Health Policy
Current Research and Scholarly Interestsclinical epidemiology, health services research, decision sciences, clinical trials in acute and chronic kidney disease
-
Ramsey Cheung
Professor of Medicine (Gastroenterology and Hepatology)
Current Research and Scholarly InterestsDr. Cheung's research interests focus on liver diseases, with emphasis on viral hepatitis. His past research include investigating the mechanism of viral neutralization of hepatitis B virus at the molecular level and immune response to hepatitis C virus. Dr. Cheung is studing various aspects of hepatitis C, both clinical and translational research.
-
Michelle Chiu, MD
Clinical Assistant Professor, Medicine
BioMichelle Chiu graduated medical school from Case Western Reserve University School of Medicine and completed internal medicine residency at Stanford University. She is currently a clinical assistant professor in the Division of Hospital Medicine at Stanford Hospital. Outside her clinical work, Dr. Chiu is involved in medical education at the graduate and post-graduate level. She teaches IM Bedside Clinical Reasoning and Physical Diagnosis Rounds, an elective for second-year PA and medical students that focuses on the bridging the gap between classroom physiology and bedside pathology. Additionally, she is involved in APP post-graduate education with current projects in hospital medicine onboarding, CME, and scholarship.
-
Mildred Cho, PhD
Professor (Research) of Pediatrics (Center for Biomedical Ethics) and of Medicine (Primary Care and Population Health)
Current Research and Scholarly InterestsDr. Cho's major areas of interest include: ethical and social issues in genetic research, including those arising from gene therapy and editing, synthetic biology, microbiome research, the use of artificial intelligence to analyze genomic and medical data, the effects of gene patenting on clinical genetic testing and research, and the impacts of academic-industry ties on biomedical research.
-
Curtis R. Chong, MD, PhD, MPhil, FACP
Clinical Assistant Professor, Medicine - Oncology
BioDr. Chong was recruited to Stanford from the Memorial Sloan Kettering (MSK) Cancer Center, where he led MSK's launch of the early drug development and immunotherapy clinical trials program in New Jersey. At MSK, Dr. Chong was a member of the gastrointestinal oncology service and was one of two MSK physicians in New Jersey who specialized in treating melanoma. Prior to joining MSK, Dr. Chong was a member of the thoracic oncology service at the Dana-Farber Cancer Institute and an attending physician at the Massachusetts General Hospital and Brigham and Women's Hospital, all ailiates of Harvard Medical School.
Dr. Chong completed his categorical residency in internal medicine at the Massachusetts General Hospital/Harvard Medical School, his oncology fellowship at the Dana-Farber Cancer Institute, and is board-certified in internal medicine and medical oncology. He has received research support from the American Society of Clinical Oncology (Young Investigator Award), Uniting Against Lung Cancer, and the American Cancer Society. Dr. Chong has been published in the New England Journal of Medicine, Nature, Nature Medicine, Nature Chemical Biology, JAMA Oncology, and his research on drug discovery has been featured in the New York Times and Popular Science.
Born and raised in Honolulu where he attended public schools, Dr. Chong sang in the Honolulu Boy Choir, and was the 1993 Honolulu Star Bulletin Newspaper Boy of the Year. He received his A.B. in biochemical sciences from Harvard University magna cum laude followed by an M.Phil. in Chemistry with Sir Alan Fersht at the University of Cambridge (Emmanuel College). He then received his MD and PhD in pharmacology from The Johns Hopkins University School of Medicine.
An intrepid traveler and avid long-distance runner, Dr. Chong has visited 54 countries and completed 126 marathons in all 50 states, 18 countries, and 6 on continents. -
Antonios Chronopoulos
Instructor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsMy research focuses on understanding how extracellular matrix (ECM) remodeling in liver fibrosis, particularly in the context of aging, diabetes, and metabolic-associated steatohepatitis (MASH), disrupts tissue mechanical homeostasis and drives hepatocellular carcinoma pathogenesis. The goal is to translate these mechanobiological insights into novel therapies targeting mechanotransduction to prevent or reverse fibrosis and improve patient outcomes with liver cancer and other desmoplastic tumors
-
Alvina Dor-Yan Chu
Adjunct Clinical Assistant Professor, Medicine - Immunology & Rheumatology
BioAlvina Chu, MD, is an adjunct clinical faculty member within the Division of Immunology and Rheumatology. She has practiced rheumatology for more than 10 years, specializing in treatment of a wide range of chronic inflammatory conditions including rheumatoid arthritis, lupus, vasculitis, and gout.
She holds a longstanding scientific interest in immunology, especially the role of B-cell signaling mechanisms in lupus and other autoimmune diseases.
In addition to taking care of patients in clinic and in the hospital, Dr. Chu enjoys teaching and mentoring fellows, residents, and medical students. -
Gilbert Chu
Professor of Medicine (Oncology) and of Biochemistry
Current Research and Scholarly InterestsAfter shuttering the wet lab, we have focused on: a point-of-care device to measure blood ammonia and prevent brain damage; a human protein complex that juxtaposes and joins DNA ends for repair and V(D)J recombination; and strategies for teaching students and for reducing selection bias in educational programs.
-
Weihan Chu
Clinical Assistant Professor, Medicine
BioWeihan Chu, M.D., serves as a Clinical Assistant Professor at Stanford School of Medicine. He obtained his M.D. from Case Western Reserve University and completed both his internship and residency at Stanford Hospital. Since 2015, Dr. Chu has been an academic hospitalist at Stanford Health Care Tri-Valley Hospital.
As the Associate Chief Medical Officer and Medical Informatics Director at SHC Tri-Valley, Dr. Chu is committed to leveraging technology to enhance patient care. He focuses on improving patient safety, ensuring regulatory compliance, and strengthening infection control measures. Additionally, he leads the implementation of new telemedicine technologies to introduce specialty services to the hospital and drives multi-disciplinary change processes to optimize hospital workflow and outcomes.
In his personal time, Dr. Chu enjoys hiking, scuba diving, photography, and keeping up with the latest tech gadgets. -
Katrin Chua
Professor of Medicine (Endocrinology, Gerontology and Metabolism)
Current Research and Scholarly InterestsOur lab is interested in understanding molecular processes that underlie aging and age-associated pathologies in mammals. We focus on a family of genes, the SIRTs, which regulate stress resistance and lifespan in lower organisms such as yeast, worms, and flies. In mammals, we recently uncovered a number of ways in which SIRT factors may contribute to cellular and organismal aging by regulating resistance to various forms of stress. We have now begun to characterize the molecular mechanisms by which these SIRT factors function. In particular, we are interested in how SIRT factors regulate chromatin, the molecular structure in which the DNA of mammalian genomes is packaged, and how such functions may link genome maintenance to stress resistance and aging.
-
Lorinda Chung
Professor of Medicine (Immunology and Rheumatology) and, by courtesy, of Dermatology
Current Research and Scholarly InterestsMy research interests focus on all aspects of systemic sclerosis. I am currently involved in clinical, translational, and epidemiologic research in these areas, and dedicate a substantial portion of my research time to investigator-initiated and multi-center clinical trials of novel therapeutics for the treatment of systemic sclerosis.
-
Daniel Clark, MD, MPH
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
Clinical Assistant Professor, Pediatrics - CardiologyBioDr. Clark is a board-certified, fellowship-trained cardiologist with the Adult Congenital Heart Program at Stanford Health Care. He is also a clinical assistant professor with dual appointments in the Division of Cardiovascular Medicine, Department of Medicine and the Division of Cardiology, Department of Pediatrics at Stanford University School of Medicine.
Dr. Clark specializes in the diagnosis and treatment of adult congenital heart disease (ACHD) and the management of congenital and acquired heart disease in children. His clinical focus involves the combined use of cardiac magnetic resonance (CMR) and other imaging techniques to evaluate patients with known or suspected cardiovascular disease. Dr. Clark’s extensive training and experience with these techniques include multiple fellowships in adult cardiology, cardiovascular imaging, and ACHD.
Dr. Clark is currently a co-investigator on multiple research studies. During his fellowship, he received a training grant from the National Institutes of Health enabling evaluation of the ability of CMR to diagnose COVID-19-associated heart inflammation among college athletes. He currently uses CMR to assess heart transplant outcomes in donors positive for hepatitis C virus. Dr. Clark also received a research grant from the Adult Congenital Heart Disease Association supporting a randomized, controlled clinical trial of cardiac rehabilitation among patients with Fontan failure.
Dr. Clark serves as a peer reviewer for multiple prestigious journals, including The New England Journal of Medicine, Circulation, Journal of the American College of Cardiology, and Journal of the American Heart Association (JAHA). He serves on the editorial board for both JAHA and Circulation: Cardiovascular Imaging. He is also a member of numerous professional medical societies, including the American College of Cardiology, the American Heart Association, and the Adult Congenital Heart Association. -
John Clarke
Clinical Professor, Medicine - Gastroenterology & Hepatology
BioDr. John Clarke recently joined the Gastroenterology & Hepatology Division at Stanford University as Director of the Esophageal Program. He previously spent 17 years in Baltimore, including 9 years on the faculty at Johns Hopkins University where he was an Associate Professor and at various times Director of Esophageal Motility, Director of Gastrointestinal Motility, Clinical Director of the Johns Hopkins Center for Neurogastroenterology, and Clinical Director of the Gastroenterology & Hepatology Division at Johns Hopkins Bayview Medical Center.
His career has combined research, education and clinical care. His clinical areas of expertise include achalasia, dysphagia, eosinophilic esophagitis, esophageal dysmotility, gastroesophageal reflux disease, gastroparesis, GI-manifestations of scleroderma and GI dysmotility. While at Johns Hopkins University, he was inducted into The Miller-Coulson Academy for Clinical Excellence, an institutional honor society for master clinicians at the time limited to 50 members across the entire university.
From an education standpoint, he has lectured in over a dozen countries, authored over 25 textbook chapters and serves on the educational affairs committee of the American College of Gastroenterology. He has also won several major teaching awards, including The Johns Hopkins University Alumni Association Award for Excellence in Teaching, given to one faculty member per year in the entire School of Medicine.
His research has focused on optimization and characterization of diagnostic studies to evaluate motility disorders, as well the relationship between therapeutic endoscopic techniques and treatment of motility disorders. He was an investigator on the NIH Gastroparesis Consortium and is also a former recipient of the AGA Don Castell Award. -
Michael F. Clarke, M.D.
Karel H. and Avice N. Beekhuis Professor of Cancer Biology
Current Research and Scholarly InterestsDr. Clarke maintains a laboratory focused on two areas of research: i) the control of self-renewal of normal stem cells and diseases such as cancer and hereditary diseases; and ii) the identification and characterization of cancer stem cells. His laboratory is investigating how perturbations of stem cell regulatory machinery contributes to human disease. In particular, the laboratory is investigating epigenetic regulators of self renewal, the process by which stem cells regenerate themselves.
-
Shoa L. Clarke, MD, PhD
Assistant Professor of Medicine (Cardiovascular Medicine) and of Pediatrics
BioDr. Clarke is a preventive cardiologist and a physician-scientist focused on disease prevention. He earned his undergraduate degree in human biology from the Division of Nutritional Sciences at Cornell University before obtaining his MD and PhD (genetics) from Stanford University School of Medicine. He has completed clinical training in internal medicine (Brigham & Women’s Hospital), pediatrics (Boston Children’s Hospital), and cardiovascular medicine (Stanford Hospital), and he is board certified in all three specialties. His research is focused on 1) understanding complex disease genetics in diverse populations, 2) integrating monogenic and polygenic risk with clinical risk, 3) large-scale phenotyping using the electronic health record and medical images. His clinical practice focuses on identifying risk factors for cardiovascular disease with the goal of promoting health and longevity through evidence-based personalized treatment. He is interested in developing family-centric approaches for the treatment of adults and children carrying genetic risk for disease.
-
William Clusin, MD
Associate Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsCardiac action potentials; tissue culture, voltage, clamp technique; role of calcium in ischemia arrhythmias; coronary, artery disease; myocardial infarction.
-
Stanley N. Cohen, MD
Kwoh-Ting Li Professor in the School of Medicine, Professor of Genetics and of Medicine
Current Research and Scholarly InterestsWe study mechanisms that affect the expression and decay of normal and abnormal mRNAs, and also RNA-related mechanisms that regulate microbial antibiotic resistance. A small bioinformatics team within our lab has developed knowledge based systems to aid in investigations of genes.
-
Elana Trubowitch Cohn
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Elana Cohn (She/Her) is a board-certified Family Physician, with a love for caring for the whole person and the entire family.
She completed her bachelor's degree in Neuroscience and Behavior at Barnard College, after which she worked as a Health Outreach coordinator on a mobile medical van providing care to the homeless population in NY, which sparked her love for primary care. She received her medical degree at Tel aviv University, and completed her residency at Mount Sinai and the Institute for Family Health.
Her practice spans care for all ages, with an emphasis on care for marginalized populations, reproductive health, office based-procedures, and teaching. She is passionate about integrating mental health care and reproductive justice into general practice, and making care for her patients as comprehensive as possible.
Outside of the office, she loves to travel and explore new places, dance her heart out, and spend time with her family. -
A. Dimitrios Colevas, MD
Professor of Medicine (Oncology) and, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS) and of Radiation Oncology (Radiation Therapy)
Current Research and Scholarly InterestsMulti- modality treatment of Head and Neck Cancer
Phase 1 clinical trials -
John P. Cooke, MD, PhD
Professor of Medicine (Cardiovascular Medicine), Emeritus
Current Research and Scholarly InterestsOur translational research program in vascular regeneration is focused on generating and characterizing vascular cells from human induced pluripotential stem cells. We are also studying the therapeutic application of these cells in murine models of peripheral arterial disease. In these studies we leverage our longstanding interest in endothelial signaling, eg by nitric oxide synthase (NOS) as well as by nicotinic cholinergic receptors (nAChR).
-
Allen Cooper
Professor of Medicine (Gastroenterology and Hepatology), Emeritus
Current Research and Scholarly InterestsI have had a long standing interest in the liver's role in cholesterol and lipid metabolism. In the past this was focused on laboratory studies but currently involves human studies as part of my patient care responsibilities. In particular I am interested in the role of NAFLD (non-alcoholic fatty liver disease) in patients with Hepatitis C aand in post liver transplant patients.
-
Steven M. Corsello
Assistant Professor of Medicine (Oncology) and, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsOur laboratory operates at the intersection of functional genomics and chemical biology, with the goal of advancing novel molecular mechanisms of cancer inhibition to clinical use. We aim to 1) leverage phenotypic screening and functional genomics to determine novel anti-cancer mechanisms of small molecules, 2) develop new targeted therapy approaches against solid tumors, and 3) build a comprehensive community resource for drug repurposing discovery.
-
Alexandra Cours, MD
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Cours is a clinician educator in geriatrics. She cares for patients as a primary care physician for older adults and as a geriatric medicine consultant in Stanford Hospital. She conducts research on bone and muscle health and leads a personal and professional development program for geriatrics fellows.
-
Lawrence Crapo
Professor of Medicine (Endocrinology, Gerontology and Metabolism) at the Santa Clara Valley Medical Center, Emeritus
Current Research and Scholarly InterestsInvestigation of the epidemiology of diabetic ketoacidosis (DKA) at a public hospital. All cases of DKA at SCVMC occurring over the past 5 years have been identified. Of the 480 cases of DKA, about 1/3 are in Type II diabetics, and 2/3 in Type I diabetics. We are exploring the causes of DKA in the two groups.
-
Meredith Craven, PhD, MPH
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsDr. Craven’s research reflects her background and interests in psychogastroenterology (GI psychology), public health, and positive psychology. She has collaborated on projects across the spectrum of GI disorders, using quantitative and qualitative methods. She is interested in the role of biopsychosocial factors on symptom perception, experience, and related health outcomes and behaviors. In particular, she is passionate about investigating the role of patient strengths that can be fostered clinically, and mind-body practices.
-
Alia Crum
Associate Professor of Psychology and, by courtesy, of Medicine (Primary Care & Population Health)
Current Research and Scholarly InterestsOur lab focuses on how subjective mindsets (e.g., thoughts, beliefs and expectations) can alter objective reality through behavioral, psychological, and physiological mechanisms. We are interested in understanding how mindsets affect important outcomes both within and beyond the realm of medicine, in the domains such as exercise, diet and stress. https://mbl.stanford.edu/
-
Nancy Cuan, MD
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Nancy Cuan is an internal medicine primary care physician at Stanford Coordinated Care (SCC). SCC is a primary care medicine practice that is a benefit for eligible members of the Stanford University, Stanford Health Care, SLAC and Lucile Packard Children’s Hospital community and their covered adult dependents with ongoing health conditions. More information, including a self-assessment to determine eligibility based on health condition(s) and health insurance, can be found at the Stanford Coordinated Care website.
Prior to joining Stanford Coordinated Care, she had practiced for many years at Santa Clara Valley Medical Center and helped with the resident training program there. She has had experience in working with patients with multiple ongoing medical conditions. -
Christina Curtis
RZ Cao Professor, Professor of Genetics and of Biomedical Data Science
Current Research and Scholarly InterestsThe Curtis laboratory for Cancer Computational and Systems Biology is focused on the development and application of innovative experimental, computational, and analytical approaches to improve the diagnosis, treatment, and early detection of cancer.